Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular Carcinoma

Background. Hepatocellular carcinoma (HCC) is one of the most common malignant cancers with a poor prognosis. Several commonly investigated immunohistochemical markers in resected HCC have potential prognostic value, but the prognostic utility of p53 expression in HCC has remained elusive. Aim. To e...

Full description

Saved in:
Bibliographic Details
Main Authors: Taewoo Yang, Yegyun Choi, Jae Won Joh, Steve K. Cho, Dae-Shick Kim, Sung-Gyoo Park
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2019/9015453
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552632705613824
author Taewoo Yang
Yegyun Choi
Jae Won Joh
Steve K. Cho
Dae-Shick Kim
Sung-Gyoo Park
author_facet Taewoo Yang
Yegyun Choi
Jae Won Joh
Steve K. Cho
Dae-Shick Kim
Sung-Gyoo Park
author_sort Taewoo Yang
collection DOAJ
description Background. Hepatocellular carcinoma (HCC) is one of the most common malignant cancers with a poor prognosis. Several commonly investigated immunohistochemical markers in resected HCC have potential prognostic value, but the prognostic utility of p53 expression in HCC has remained elusive. Aim. To evaluate the prognostic value of p53 and p53 phosphorylation at serine 15 (p53 Ser15-P) in patients with HCC. Methods. Surgically resected tumors from 199 HCC patients were analyzed for p21, p53, p53 Ser15-P, and proliferating cell nuclear antigen (PCNA) expression using immunohistochemistry. Results. Stratifying by the expression of p53 Ser15-P (P = 0.016), but not by p53 (P = 0.301), revealed significantly different survival outcomes in patients with HCC. Moreover, our analysis demonstrated that patients who were PCNA-positive and p53 Ser15-P–negative had significantly worse survival outcomes (P = 0.001) than patients who were PCNA-positive and p53 Ser15-P–positive. Conclusions. P53 Ser15-P is associated with poor outcomes in patients with HCC, and this prognostic marker is useful for predicting the survival of patients with PCNA-positive HCC.
format Article
id doaj-art-41a38ee0b95e44f98f892d5ade5c0eb1
institution Kabale University
issn 2291-2789
2291-2797
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-41a38ee0b95e44f98f892d5ade5c0eb12025-02-03T05:58:12ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972019-01-01201910.1155/2019/90154539015453Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular CarcinomaTaewoo Yang0Yegyun Choi1Jae Won Joh2Steve K. Cho3Dae-Shick Kim4Sung-Gyoo Park5School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaDepartment of Surgery, Samsung Medical Center, Seoul 06351, Republic of KoreaSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaDepartment of Pathology, Samsung Medical Center, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaSchool of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaBackground. Hepatocellular carcinoma (HCC) is one of the most common malignant cancers with a poor prognosis. Several commonly investigated immunohistochemical markers in resected HCC have potential prognostic value, but the prognostic utility of p53 expression in HCC has remained elusive. Aim. To evaluate the prognostic value of p53 and p53 phosphorylation at serine 15 (p53 Ser15-P) in patients with HCC. Methods. Surgically resected tumors from 199 HCC patients were analyzed for p21, p53, p53 Ser15-P, and proliferating cell nuclear antigen (PCNA) expression using immunohistochemistry. Results. Stratifying by the expression of p53 Ser15-P (P = 0.016), but not by p53 (P = 0.301), revealed significantly different survival outcomes in patients with HCC. Moreover, our analysis demonstrated that patients who were PCNA-positive and p53 Ser15-P–negative had significantly worse survival outcomes (P = 0.001) than patients who were PCNA-positive and p53 Ser15-P–positive. Conclusions. P53 Ser15-P is associated with poor outcomes in patients with HCC, and this prognostic marker is useful for predicting the survival of patients with PCNA-positive HCC.http://dx.doi.org/10.1155/2019/9015453
spellingShingle Taewoo Yang
Yegyun Choi
Jae Won Joh
Steve K. Cho
Dae-Shick Kim
Sung-Gyoo Park
Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular Carcinoma
Canadian Journal of Gastroenterology and Hepatology
title Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular Carcinoma
title_full Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular Carcinoma
title_fullStr Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular Carcinoma
title_full_unstemmed Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular Carcinoma
title_short Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular Carcinoma
title_sort phosphorylation of p53 serine 15 is a predictor of survival for patients with hepatocellular carcinoma
url http://dx.doi.org/10.1155/2019/9015453
work_keys_str_mv AT taewooyang phosphorylationofp53serine15isapredictorofsurvivalforpatientswithhepatocellularcarcinoma
AT yegyunchoi phosphorylationofp53serine15isapredictorofsurvivalforpatientswithhepatocellularcarcinoma
AT jaewonjoh phosphorylationofp53serine15isapredictorofsurvivalforpatientswithhepatocellularcarcinoma
AT stevekcho phosphorylationofp53serine15isapredictorofsurvivalforpatientswithhepatocellularcarcinoma
AT daeshickkim phosphorylationofp53serine15isapredictorofsurvivalforpatientswithhepatocellularcarcinoma
AT sunggyoopark phosphorylationofp53serine15isapredictorofsurvivalforpatientswithhepatocellularcarcinoma